24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Sol-Gel
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:08
OnePlus 15 review: Bigger battery, lower price, and a familiar flagship formula
11:59
The Nvidia effect: A rural valley faces an urban-scale shock
09:44
The end of the "garage era" - breakthroughs in AI need the academia
09:04
Israeli startups raised $15.6 billion in 2025 as AI drove bigger, more concentrated bets
More stories
Buzz
Most popular
Daily
Weekly
1
Weapons as strategy: Israel’s defense industry steps into a larger global role
2
Huang declares Israel Nvidia’s “second home” with record-breaking campus investment
3
The end-of-year tech layoffs are not a crisis - they mark a paradigm shift
4
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
5
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
More news
Sol-Gel
3 stories about Sol-Gel
Perrigo to Collaborate with Acne Cream Company Sol-Gel on Generic Drug
16.08.18
|
CTech
Nasdaq-listed Sol-Gel is a clinical-stage company developing topical products for skin conditions
Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO
31.08.17
|
Dror Reich
The clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology
Anti-Acne Drug Developer Plans Nasdaq IPO
15.08.17
|
Golan Hazani
Sol-Gel approached potential underwriters. It aims to go public before the end of the year